Myeloid neoplasms arising after methotrexate therapy for autoimmune rheumatological diseases do not exhibit poor-risk molecular features-Reference-Cited by-同舟云学术

Myeloid neoplasms arising after methotrexate therapy for autoimmune rheumatological diseases do not exhibit poor-risk molecular features

Published:2024-07-19 Issue:1 Volume:14 Page:
ISSN:2044-5385
Container-title:Blood Cancer Journal
language:en
Short-container-title:Blood Cancer J.

Author:

Wechalekar Mihir D.,Zhao Lin-Pierre^ORCID,Kutyna Monika M.,Hong Lih En,Li Joule,Hung Kevin^ORCID,Scott Hamish S.^ORCID,Brown Anna^ORCID,Hahn Christopher C.^ORCID,Kassahn Karin,Ladon Dariusz,Yeung David T.,Thomas Daniel,Patnaik Mrinal^ORCID,Proudman Susanna,Ades Lionel^ORCID,Shah Mithun V.^ORCID,Kok Chung H.^ORCID,Hiwase Devendra K.^ORCID

Funder

Department of Health | National Health and Medical Research Council

Publisher

Springer Science and Business Media LLC

Link

https://www.nature.com/articles/s41408-024-01093-9.pdf

Reference14 articles.

1. Komrokji RS, Kulasekararaj A, Al Ali NH, Kordasti S, Bart-Smith E, Craig BM, et al. Autoimmune diseases and myelodysplastic syndromes. Am J Hematol. 2016;91:E280–3. https://doi.org/10.1002/ajh.24333.

2. Watad A, Kacar M, Bragazzi NL, Zhou Q, Jassam M, Taylor J, et al. Somatic mutations and the risk of undifferentiated autoinflammatory disease in MDS: an under-recognized but prognostically important complication. Front Immunol. 2021;12:610019 https://doi.org/10.3389/fimmu.2021.610019

3. Mekinian A, Grignano E, Braun T, Decaux O, Liozon E, Costedoat-Chalumeau N, et al. Systemic inflammatory and autoimmune manifestations associated with myelodysplastic syndromes and chronic myelomonocytic leukaemia: a French multicentre retrospective study. Rheumatology (Oxford). 2016;55:291–300. https://doi.org/10.1093/rheumatology/kev294.

4. Zhao LP, Boy M, Azoulay C, Clappier E, Sebert M, Amable L, et al. Genomic landscape of MDS/CMML associated with systemic inflammatory and autoimmune disease. Leukemia. 2021;35:2720–4. https://doi.org/10.1038/s41375-021-01152-1.

5. Ertz-Archambault N, Kosiorek H, Taylor GE, Kelemen K, Dueck A, Castro J, et al. Association of therapy for autoimmune disease with myelodysplastic syndromes and acute myeloid leukemia. JAMA Oncol. 2017;3:936–43. https://doi.org/10.1001/jamaoncol.2016.6435.